MEDI — Medistim ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK3.58bn
- NOK3.42bn
- NOK562.60m
- 95
- 19
- 91
- 82
Annual cashflow statement for Medistim ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 69.4 | 90.9 | 114 | 135 | 134 |
| Depreciation | |||||
| Non-Cash Items | -19 | -13.3 | -19.2 | -25.7 | -27.3 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.649 | 27.1 | -4.6 | -20 | 11.7 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 74.1 | 128 | 113 | 113 | 143 |
| Capital Expenditures | — | -11.5 | -21.1 | -29.7 | -24.7 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -10.6 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -10.6 | -11.5 | -21.1 | -29.7 | -24.7 |
| Financing Cash Flow Items | 1.39 | 7.59 | 5.4 | 6.01 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -58.3 | -59.1 | -70.3 | -84.9 | -91.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.15 | 57.6 | 23.2 | 1.23 | 25.3 |